AN2 Therapeutics (ANTX)

• Market cap: $193M
• 1 day: 0.38%
• 5 days: 7.86%
• 1 month: 10.54%
• 3 months: 17.58%
• 6 months: 377.68%
• Year to date: 381.98%
• 1 year: 404.72%
• 5 years: -65.26%
• 10 years: -65.26%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Employees: 21